This is a community-generated profile. If you would like to claim it, please .
Cellerant Therapeutics Funding
$96.2M
99 rounds
Cellerant Therapeutics is active in the following markets / industries: biotechnology. The company has secured funding across 9 rounds, totaling in an amount of $96.2M. Their most recent funding was raised on September 11, 2014.
Funding Rounds
U
$47500000U
$2200000U
$2100000U
$16700000U
$800000U
$2000000U
$4500000B
$4400000Investors of Cellerant Therapeutics
CX Venture Group
Camelot Venture Group
Allen & Company
Rounds
U
B
MPM Capital
Rounds
B